DSDyego Luiz Pereira Lima DE Melo E Silva

Dyego Luiz Pereira Lima DE Melo E Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dyego Luiz Pereira Lima DE Melo E Silva has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of Hypovitaminosis D and Its Association with Motor Impairment in Spinal Muscular Atrophy

    by Dallianny Paulino Martins de Andrade, Antônio Vicente Dias de Andrade, Paloma Katlheen Moura Melo, Thais Araújo Barbosa, Dyego Luiz Pereira Lima de Melo e Silva, José Rodolfo Lopes de Paiva Cavalcanti, Epitácio Leite Rolim Filho

    Background/Objectives: In recent years, the role of vitamin D in the etiology of central and peripheral neurological diseases has been widely investigated, and evidence suggests benefits of vitamin D replacement therapy. However, few studies have evaluated the relationship between serum vitamin D levels and patients with spinal muscular atrophy (SMA). Therefore, this study aimed to analyze serum vitamin D levels in patients with SMA and their relationship with disease type, degree of motor impairment, and the presence of musculoskeletal deformities. Methods: This was a cross-sectional analytical study conducted with patients diagnosed with SMA who were treated at a Rare Diseases Reference Service in Recife, Pernambuco, Brazil. Serum vitamin D levels and their association with clinical characteristics of the disease, including SMA type, motor impairment, and the presence of musculoskeletal deformities were evaluated. Motor impairment was classified according to functional capacity, and an ordinal score was used for correlation analysis. Results: The sample consisted of 36 patients with SMA. The mean serum 25(OH)D concentration was 28.95 ± 10.28 ng/mL, with values ranging from 8.3 to 49.4 ng/mL. Based on the predefined cutoff of 30 ng/mL, 58.3% of participants had serum 25(OH)D concentrations below 30 ng/mL, whereas 41.7% had concentrations ≥30 ng/mL. Serum 25(OH)D concentrations differed significantly across motor function groups (p = 0.002). However, correlation analysis showed a weak and non-significant correlation between motor impairment and serum 25(OH)D concentrations (Spearman r = −0.136; p = 0.431; (n = 36). An association between hypovitaminosis D and the presence of musculoskeletal deformities was also observed. Conclusions: Hypovitaminosis D showed a high prevalence in patients with SMA. Although serum 25(OH)D concentrations differed significantly across motor function groups, the correlation between motor impairment and serum 25(OH)D concentrations was weak and non-significant. These findings reinforce the importance of monitoring serum vitamin D levels and adopting clinical and nutritional follow-up strategies in this population.

  • Open Access

    BONE MARROW ASPIRATE IN SPINAL ARTHRODESIS: SYSTEMATIC REVIEW OF EFFICACY AND SAFETY

    by Anderson Matheus Medeiros DE Araújo, Marcus André Costa Ferreira, André Flávio Freire Pereira, Luciano Temporal Borges Cabral, Túlio Albuquerque DE Moura Rangel, Rodrigo Castro DE Medeiros, Dyego Luiz Pereira Lima DE Melo E Silva, Luiz Pedro Marques Gomes, Luis Menezes DA Fonseca Neto, Pedro Vitor Soares Fonseca, et al.

    Iliac Crest Bone Graft (ICBG) has historically been recognized as the gold standard in spinal arthrodesis procedures. However, its use is intrinsically associated with donor site complications, including chronic pain, paresthesia, risk of infection, and the limitation of available bone volume for harvesting. These disadvantages have motivated the exploration of biologically compatible and less invasive alternatives, such as Bone Marrow Aspirate (BMA). Although preliminary publications suggest favorable results, uncertainties persist regarding the actual effectiveness and safety of BMA in vertebral arthrodesis. Thus, the present study is a systematic review of the literature, conducted in accordance with the PRISMA Guidelines, whose primary objective was to evaluate the safety and clinical efficacy of BMA in spine arthrodesis procedures. The methodological quality of the identified Randomized Clinical Trials (RCTs) was assessed using the PEDro scale. The bibliographic search was performed by two independent reviewers in the Pubmed, Web Of Science, Scopus, and Embase databases, covering the period from 2005 to 2024. The descriptors “Bone Marrow Aspirate” OR “BMA” AND “Spine Fusion” OR “Spine Arthrodesis” were used, with the application of filters for “Randomized Controlled Trial,” “Meta-Analysis,” and “Systematic Reviews.” After screening and methodological evaluation, the final sample consisted of 14 studies. The consolidated data analysis demonstrated that BMA, notably when used in combination with synthetic grafts, presents satisfactory results concerning fusion rates, postoperative pain levels, and functional outcomes. These findings position BMA as a clinically viable alternative to ICBG. Level of Evidence II; Systematic Review.